Sublingual ketamine deal opens chronic dosing opportunity
To view this email as a web page, click here

Today's Rundown

Featured Story

Omicron spurs Celltrion to accelerate development of nebulized COVID-19 antibody cocktail

With the mix of mutations in omicron raising fears the new COVID-19 virus will evade our existing defenses, Celltrion is stepping up work on a nebulized cocktail it thinks may remain effective against the pathogen.

read more

Top Stories

Chinese firms win subcutaneous checkpoint inhibitor approval, beating global heavyweights to new opportunity 

A trio of Chinese biopharma companies has won the first approval for a subcutaneous checkpoint inhibitor, beating rivals including Merck and Pfizer by securing authorization in its home market. 

read more

Seelos eyes chronic ketamine dosing after bagging rights to sublingual candidate

Seelos Therapeutics has secured near-global rights to a sublingual ketamine wafer, agreeing to pay iX Biopharma $9 million upfront to take control of a candidate it envisages unlocking chronic use of the drug.

read more

EpiPen rival Kaléo snapped up in $310M deal by investor group

Kaléo, a small drugmaker and EpiPen rival, has been acquired by Marathon Asset Management in a deal valued at $310 million. The funding is expected to fuel the company’s growth in the allergy treatment arena and beyond.

read more

'What it takes': Beyond the headlines, women are pushing groundbreaking new Alzheimer's treatments forward

As Fierce Biotech reported out the aftermath of the controversial approval of Biogen’s Aduhelm, we discovered a common thread at many of the top pharma companies who are working on the most advanced treatments in development: women. We wanted to know—how have they kept going?

read more

Resources

Guide: Top 10 Considerations When Implementing Machine Translation

If you’re thinking about leveraging the benefits of increased quality, reduced costs, and shortened turnaround times that machine translation (MT) has to offer, check out this quick guide for the top 10 considerations when implementing MT.

Whitepaper: Medable was able to cut costs in multiple clinical trials by over US$25,000,000

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: How the Chronic Insomnia Market Raises Big Questions About Digital Therapeutics

Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Events